Theranica Expands Accessibility of Nerivio™ to U.S. Migraine Patients Via Partnership With Telemedicine Platform, Cove

Cove Provides Rapid Consultation with a Licensed Physician and Home Delivery of the Novel FDA-Authorized Prescribed Wearable Device

NETANYA, Israel, and NEW YORKFeb. 25, 2020 /PRNewswire/ — Theranica Bioelectronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain conditions, and Cove, a healthcare company that provides increased access to innovative migraine treatments, alongside ongoing migraine management, announced today the expanded availability of Nerivio™, a novel FDA-authorized prescribed wearable for acute treatment of migraine, on Cove’s advanced telemedicine platform. Read more…

There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone.

If you live with or work with someone who suffers from migraine, there’s something very important you should know: A migraine is not “just a headache,” as many seem to think. Nor is it something most sufferers can simply ignore and get on with their lives.

And if you are a migraine sufferer, there’s something potentially life-changing that you should know: There are now a number of medications available that can either prevent or alleviate many attacks, as well as a newly marketed wearable nerve-stimulating device that can be activated by a smartphone to relieve the pain of migraine. Read more…


NETANYA, IsraelDec. 3, 2019 /PRNewswire/ — Theranica Bio-Electronics (Theranica), a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the journal of Expert Review of Medical Devices has published a device profile of its novel smartphone-controlled, prescription migraine wearable device, Nerivio™. The article explores the safety and efficacy of the product, demonstrating the promise of the FDA-cleared remote electrical neuromodulation (REN) device among traditional pharmacological therapies as a highly effective and affordable wearable that has a favorable safety and tolerability profile.

Read more…

Every year, TIME highlights the Best Inventions that are making the world better, smarter and even a bit more fun.

Of the ten healthcare companies selected, two of LionBird’s portfolio companies made the list – Theranica and Tyto.

See the full list.

NETANYA, IsraelNov. 8, 2019 /PRNewswire/ — Theranica Bio-Electronics Ltd., a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the American Headache Society published an article in its peer-reviewed journal, Headache: The Journal of Head and Face Pain, highlighting the promise of Remote Electrical Neuromodulation (REN) as an alternative to current treatment options and as a potential first-line therapy for acute migraine relief.

Read more…

Privately owned Theranica Bioelectronics is aiming to reshape the way migraines are treated in patients all around the world.

The company, which was founded three years ago, is using advanced neuromodulation therapy with wireless technology to develop electroceuticals for migraines and other pain disorders.

Read more…

Headache Researchers in California and Missouri Conducted a Per-Patient Comparison of FDA-Cleared Wearable Device with Contemporary Usual Care

Theranica, a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today the publication of a peer-reviewed paper demonstrating that Remote Electrical Neuromodulation (REN) is as effective as acute pharmacological treatments in treating the symptoms of migraine.

Read more…

BETHESDA, Md. (WPVI) — The government has OK’d a new non-invasive device to relieve the pain of acute migraine.

And this device is controlled from your smartphone.

The Nerivio Migra is a wearable device that goes on the upper arm.

It was invented by Theranica, an Israeli company, with the goal of relieving migraine pain without the side effects of medication.

Watch segment…

Nerivio Migra®, a first-in-category product, is placed on the upper arm (not the head or neck) and uses smartphone-controlled electronic pulses to create a Conditioned Pain Modulation (CPM) response.

Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced on May 28 that the U.S. Food and Drug Administration (FDA) granted a De Novo request for its smartphone-controlled electroceutical, Nerivio Migra®, utilising Remote Electrical Neuromodulation for the acute treatment of migraine.

Read more…